Blankart, K., Felder, S., (2022). Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? A Retrospective Analysis of Switzerland 2015-2020, Value in Health.

Felder, S., Sevim, D., (2022). Decision thresholds for medical tests under ambiguity aversion, Frontiers in Health Services, Cost and Resource Allocation.

Felder, S., (2022). Decision Thresholds with Genetic Testing, European Journal of Health Economics.

Felder, S., Mayrhofer, Th., (2022). Medical Decision Making, Springer (3rd ed.)

Amann, E., Felder, S., (2021). Survival of Altruistic Gatekeepers: Kickbacks in Medical Markets, German Economic Review.

Fehr, D., Fink, G., Jack, BK., (2022). Poor and Rational: Decision-Making under Scarcity, Journal of Political Economy.

Fink, G., Tediosi, F., Felder, S., (2022). Burden of Covid-19 restrictions: National, regional and global estimates, EClinicalMedicine.

Fink, G., et al., (2022). Mosquito Net Use in Early Childhood and Survival to Adulthood in Tanzania, New England Journal of Medicine.

Egger, D., et al., (2021). Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries, Science Advances.

Fink, G., Jack, BK., Masiye, F., (2020). Seasonal Liquidity, Rural Labor Markets, and Agricultural Production, American Economic Review.

Aebersold, H., et al., (2022). Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort, Heart.

Galactionova, K., et al., (2022). Cost-effectiveness, burden of disease and budget impact of inclisiran: dynamic cohort modelling of a real-world population with cardiovascular disease, Pharmacoeconomics.

Salari, P., et al., (2022). Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study, PLoS One.

Brüngger, B., et al., (2021). Surgical procedures in inpatient versus outpatient settings and its potential impact on follow-up costs, Health Policy.